Literature DB >> 15659039

Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1.

Jerry S Vande Berg1, Michael A Rose, Patricia L Haywood-Reid, Ross Rudolph, Wyatt G Payne, Martin C Robson.   

Abstract

In a 16-patient study, cultured fibroblast populations from normal skin were able to replicate an average of 14.8 +/- 2.2 times before becoming senescent, while fibroblast populations from the ulcer bed reached the end of their replicative life span after 7.2 +/- 1.9 population doublings (p= 0.001). Fibroblast populations from 10 of 16 pressure ulcers became senescent after fewer than five population doublings, whereas when populations of fibroblasts from adjacent normal skin were studied, only 2 of 16 became senescent within this same time period. In addition, only an occasional fibroblast from normal skin stained positively for senescence-associated beta-galactosidase compared to approximately 50% of equally aged ulcer bed fibroblasts (p = 0.0060). Senescent ulcer bed fibroblasts secreted significantly more plasmin than early passage ulcer bed fibroblasts (p= 0.0237), nearly six times as much plasmin as early passage normal skin fibroblasts (p < 0.0001), three and a half times the level of normal skin fibroblasts of the same age (11.52 +/- 4.58 microg/mg protein; p= 0.0003), and more than one and a half times the level of senescent normal skin fibroblasts (p= 0.0525). Senescent pressure ulcer fibroblasts generated significantly more plasminogen activator inhibitor-1 (1179.27 +/- 25.37 ng/mg protein) than normal skin fibroblasts of the same age (132.16 +/- 16.20 ng/mg protein; p = 0.0357). Also, senescent ulcer bed fibroblasts produced higher levels of transforming growth factor-beta1, but these were not significantly different from senescent normal skin fibroblasts. Although senescent ulcer fibroblasts produce elevated levels of plasminogen activator inhibitor-1 and transforming growth factor-beta1, the ratio of these factors to plasmin levels suggests that this may have little influence on extracellular matrix synthesis or maintenance in the chronic wound. These data show that cultured fibroblasts from most patient pressure ulcers profile a wound environment that is associated with an increasing population of senescent fibroblasts; however, factors within the chronic wound environment that promote cellular senescence remain unclear. We have proposed that a prolonged inflammatory response may be a contributing factor to the chronic wound condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659039     DOI: 10.1111/j.1067-1927.2005.130110.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  21 in total

1.  Chronic wounds - is cellular 'reception' at fault? Examining integrins and intracellular signalling.

Authors:  Alan D Widgerow
Journal:  Int Wound J       Date:  2012-04-11       Impact factor: 3.315

Review 2.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Skin Structure-Function Relationships and the Wound Healing Response to Intrinsic Aging.

Authors:  Michael J Blair; Jake D Jones; Alan E Woessner; Kyle P Quinn
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-24       Impact factor: 4.730

4.  Clinical strategies and animal models for developing senolytic agents.

Authors:  James L Kirkland; Tamara Tchkonia
Journal:  Exp Gerontol       Date:  2014-10-28       Impact factor: 4.032

5.  The Lipid Portion of Activated Platelet-Rich Plasma Significantly Contributes to Its Wound Healing Properties.

Authors:  Lauren Alexis Hoeferlin; Quoc K Huynh; Jennifer A Mietla; Scott A Sell; Jason Tucker; Charles Edward Chalfant; Dayanjan Shanaka Wijesinghe
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-02-01       Impact factor: 4.730

Review 6.  The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer.

Authors:  Justyna Mikuła-Pietrasik; Szymon Rutecki; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2022-03-19       Impact factor: 9.261

7.  Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.

Authors:  Elizabeth L Thompson; Louise E Pitcher; Laura J Niedernhofer; Paul D Robbins
Journal:  Plast Reconstr Surg       Date:  2021-09-28       Impact factor: 5.169

Review 8.  Cellular Senescence in Aging, Tissue Repair, and Regeneration.

Authors:  Maria Shvedova; Rex Jeya Rajkumar Samdavid Thanapaul; Elizabeth L Thompson; Laura J Niedernhofer; Daniel S Roh
Journal:  Plast Reconstr Surg       Date:  2021-09-28       Impact factor: 5.169

9.  Cellular senescence controls fibrosis in wound healing.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Aging (Albany NY)       Date:  2010-09       Impact factor: 5.682

10.  Plasminogen activator inhibitor-1: a potential etiological role in livedoid vasculopathy.

Authors:  Yimeng Gao; Hongzhong Jin
Journal:  Int Wound J       Date:  2020-10-11       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.